Description
Spironolactoneisadiureticthatinhibitsaldosteronereceptors,mineralocorticoidreceptors,androgenreceptors,andendothelialNa+channels(ENaCs).Spironolactoneexhibitsantihypertensiveactivityandisclinicallyusedtotreatheartfailure.Spironolactonemayinhibitvoltage-gatedCa2+channels.
References
YancyCW,JessupM,BozkurtB,etal.2013ACCF/AHAguidelineforthemanagementofheartfailure:areportoftheAmericanCollegeofCardiologyFoundation/AmericanHeartAssociationTaskForceonPracticeGuidelines.JAmCollCardiol.2013Oct15;62(16):e147-239.PMID:23747642.
MannSJ,ParikhNS.AsimplifiedmechaNISTicalgorithmfortreatingresistanthypertension:efficacyinaretrospectivestudy.JClinHypertens(Greenwich).2012Apr;14(4):191-7.PMID:22458739.
NappiJM,SiegA.Aldosteroneandaldosteronereceptorantagonistsinpatientswithchronicheartfailure.VascHealthRiskManag.2011;7:353-63.PMID:21731887.